A detailed history of Pathstone Holdings, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 22,449 shares of GKOS stock, worth $3.11 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,449
Previous 21,123 6.28%
Holding current value
$3.11 Million
Previous $2.5 Million 17.01%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$113.62 - $135.39 $150,660 - $179,527
1,326 Added 6.28%
22,449 $2.92 Million
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $866,613 - $1.15 Million
9,685 Added 84.67%
21,123 $2.5 Million
Q1 2024

May 13, 2024

BUY
$76.4 - $96.33 $596,149 - $751,662
7,803 Added 214.66%
11,438 $1.08 Million
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $216,391 - $309,374
3,635 New
3,635 $288,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.6B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.